Table 3E.
Metascape analysis was performed to identify pathways associated with upregulated caspase-1 dependent GSDMD secretome gene lists in various Treg groups.
Enrichment | normal spleen | normal tissue | disease spleen | disease tissue | tumor spleen | tumor tissue |
---|---|---|---|---|---|---|
Pathways in cancer | + | + | + | + | + | + |
vesicle organization | + | + | + | + | ||
negative regulation of apoptotic signaling pathway | + | + | + | |||
myeloid leukocyte activation | + | + | ||||
striated muscle cell differentiation | + | + | ||||
cell morphogenesis involved in differentiation | + | + | ||||
supramolecular fiber organization | + | + | ||||
extracellular structure organization | + | + | ||||
response to reactive oxygen species | + | + | ||||
cell-substrate junction assembly | + | + | ||||
Fluid shear stress and atherosclerosis | + | + | ||||
positive regulation of organelle organization | + | |||||
ECM-receptor interaction | + | |||||
NABA MATRISOME ASSOCIATED | + | |||||
morphogenesis of an epithelium | + | |||||
extracellular matrix disassembly | + | |||||
TNF signaling pathway | + | |||||
establishment of organelle localization | + | |||||
wound healing | + | |||||
Smooth Muscle Contraction | + | |||||
regulation of lymphocyte differentiation | + | |||||
response to peptide | + | |||||
angiogenesis | + | |||||
regulation of cell adhesion | + | |||||
Hypertrophic cardiomyopathy (HCM) | + | |||||
Diseases of signal transduction by growth factor receptors and second messengers | + | |||||
actomyosin structure organization | + | |||||
Extracellular matrix organization | + | |||||
organophosphate biosynthetic process | + | |||||
branching morphogenesis of an epithelial tube | + | |||||
epithelial cell development | + | |||||
Hemostasis | + | |||||
cellular response to external stimulus | + | |||||
carbohydrate metabolic process | + | |||||
Non-integrin membrane-ECM interactions | + | |||||
response to oxidative stress | + | |||||
post-translational protein modification | + | |||||
coenzyme metabolic process | + | |||||
cell-substrate adhesion | + | |||||
cellular response to oxygen levels | + | |||||
generation of precursor metabolites and energy | + | |||||
positive regulation of cell motility | + | |||||
MAPK signaling pathway | + | |||||
Degradation of the extracellular matrix | + | |||||
Proteoglycans in cancer | + | |||||
regulation of body fluid levels | + | |||||
regulation of cellular protein localization | + | |||||
positive regulation of binding | + | |||||
PID INTEGRIN4 PATHWAY | + | |||||
Post-translational protein phosphorylation | + | |||||
cell division | + | |||||
positive regulation of response to external stimulus | + | |||||
positive regulation of cell migration | + | |||||
chromatin remodeling | + | |||||
regulation of cholesterol metabolic process | + | |||||
response to hypoxia | + | |||||
purine nucleoside triphosphate metabolic process | + | |||||
Cell Cycle, Mitotic | + |